Elephas is a live tumor imaging company developing novel cancer diagnostic solutions to predict treatment outcomes and accelerate drug development.
Location: United States
Total raised: $136.5M
Investors 1
| Date | Name | Website |
| 08.11.2023 | ARCH Ventu... | archventur... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 07.11.2025 | Series B | $40M | Venture In... |
| 23.01.2024 | Series C | $55M | - |
| 09.09.2022 | Series B | $41.5M | - |
Mentions in press and media 13
| Date | Title | Description |
| 30.07.2026 | Advancing Personalized Cancer Treatment in Wisconsin | Elephas uses live tumor biopsy samples to evaluate drug effectiveness in real time As cancer treatment continues to evolve, one of the biggest challenges facing physicians is determining which therapies will work best for individual patient... |
| 07.11.2025 | Elephas Biosciences: $40 Million Series B-2 Raised To Advance Commercialization Of Live Tumor Profiling Platform | Elephas Biosciences has secured $40 million in Series B-2 financing to support the launch and commercialization of its Elephas Live Platform, a laboratory-developed test expected to be introduced in 2026. The company, based in Madison, Wisc... |
| 06.11.2025 | Elephas Biosciences Receives $40M Series B-2 | MADISON, WI, Elephas Biosciences today announced a Series B-2 funding of $40 million. >> Click here for more funding data on Elephas Biosciences >> To export Elephas Biosciences funding data to PDF and Excel, click here Elephas... |
| 06.11.2025 | Elephas Biosciences Raises $40M in Series B-2 Funding | Elephas Biosciences, a Madison, WI-based private company that has developed a live tumor profiling platform for immunotherapy response prediction, raised $40M in Series B-2 funding. Backers included Northpond Ventures, ARCH Venture Partners... |
| 06.08.2025 | Wisconsin startup funding dips in 2024 but deal size hits decade high | Wisconsin’s early stage companies raised a combined $374.1 million in 2024 across 92 deals, according to the Wisconsin Technology Council’s newly released Wisconsin Portfolio. While the total marked the state’s lowest since 2018, the median... |
| 23.01.2024 | Elephas Biosciences Lands $55M Series C | MADISON, WI, Elephas Biosciences Corporation (Elephas), a private company, announced today that it has raised $55 million in Series C funding. >> Click here for more funding data on Elephas Biosciences >> To export Elephas B... |
| 23.01.2024 | Elephas Biosciences raises $55 million led by Madison-based investors | - |
| 23.01.2024 | Elephas Raises $55M in Series C Funding | Elephas, a Madison, WI-based company developing an ex-vivo platform to assess how live patient biopsies respond to immunotherapies, raised $55M in Series C funding. The round, which brought the total amount to $116.5M, was led by Venture In... |
| 07.09.2022 | Elephas Biosciences Raises $41.5M in Series B Funding | Elephas Biosciences Corporation, a Madison, Wis.-based oncology diagnostics company, raised $41.5m in Series B funding. The round was led by ARCH Venture Partners, joined by new investors, Moore Strategic Ventures and Tao Capital Partners, ... |
| 06.09.2022 | Elephas Biosciences Secures $41.5M Series B | MADISON, WI, Elephas Biosciences announced today that it has raised $41.5 million in Series B funding. >> Click here for more funding data on Elephas Biosciences >> To export Elephas Biosciences funding data to PDF and Excel... |
Show more